Page last updated: 2024-10-25

deferoxamine and Lymphoma, Mantle-Cell

deferoxamine has been researched along with Lymphoma, Mantle-Cell in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Lymphoma, Mantle-Cell: A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babosova, O1
Kapralova, K1
Raskova Kafkova, L1
Korinek, V1
Divoky, V1
Prchal, JT1
Lanikova, L1

Other Studies

1 other study available for deferoxamine and Lymphoma, Mantle-Cell

ArticleYear
Iron chelation and 2-oxoglutarate-dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:11

    Topics: Amino Acids, Dicarboxylic; Cell Hypoxia; Cell Line, Tumor; Cyclin D1; Deferoxamine; Dioxygenases; DN

2019